Kezar Life Sciences, Inc. — Director's Dealing 2019

Jul 26, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Kezar Life Sciences, Inc. (KZR)
CIK: 0001645666
Period of Report: 2019-07-25

Reporting Person: Belsky Marc (CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-07-25	Common Stock	P	444	$5.654	Acquired	444	Indirect
2019-07-26	Common Stock	P	56	$5.80	Acquired	500	Indirect

Footnotes

F1: The price reported on Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $5.64 to $5.66 on July 25, 2019. The reporting person will provide upon request to the SEC, the issuer or security holder of issuer, full information regarding the number of shares purchased at each separate price.